Order Article Reprints

Jotschke S, Schulze S, Jaekel N, Ludwig-Kraus B, Engelmann R, Kraus FB, Zahn C, Nedlitz N, Prange-Krex G, Mohm J, et al. Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO). Cancers. 2022; 14(6):1544. https://doi.org/10.3390/cancers14061544

Jotschke, Sabrina, Susann Schulze, Nadja Jaekel, Beatrice Ludwig-Kraus, Robby Engelmann, Frank Bernhard Kraus, Christina Zahn, Nicole Nedlitz, Gabriele Prange-Krex, Johannes Mohm, and et al. 2022. "Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)" Cancers 14, no. 6: 1544. https://doi.org/10.3390/cancers14061544

Jotschke, S., Schulze, S., Jaekel, N., Ludwig-Kraus, B., Engelmann, R., Kraus, F. B., Zahn, C., Nedlitz, N., Prange-Krex, G., Mohm, J., Peuser, B., Schwarz, M., Spohn, C., Behlendorf, T., Binder, M., Junghanss, C., Böttcher, S., & Al-Ali, H. K. (2022). Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO). Cancers, 14(6), 1544. https://doi.org/10.3390/cancers14061544